DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹9,042 Cr | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr |
What is the latest Sundry Debtors ratio of DR REDDYS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹8,030 Cr |
| Mar2023 | ₹7,249 Cr |
| Mar2022 | ₹6,676 Cr |
| Mar2021 | ₹4,964 Cr |
How is Sundry Debtors of DR REDDYS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,042 Cr | 12.61 | |
| Mar2024 | ₹8,030 Cr | 10.78 | |
| Mar2023 | ₹7,249 Cr | 8.57 | |
| Mar2022 | ₹6,676 Cr | 34.49 | |
| Mar2021 | ₹4,964 Cr | - | |
Compare Sundry Debtors of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹107,004.4 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
| MANKIND PHARMA | ₹84,227.3 Cr | 2% | -0.6% | -16.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.3% |
-1.3% |
8.6% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses